Monday, February 9, 2026
IndiaMedToday

Dr Reddy’s launches Olopatadine Hydrochloride Ophthalmic Solution in US

IMT News Desk
IMT News Desk
· 1 min read

Dr Reddy’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 per cent is an Antihistamine eye drop, indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander

Dr Reddy’s Laboratories announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 per cent, the generic equivalent of Extra Strength Pataday Once-Daily Relief, in the US market, as approved by the US Food and Drug Administration (USFDA).

Dr Reddy’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 per cent is an Antihistamine eye drop, indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander.

“This launch adds to our current portfolio in the OTC eye-care space which includes Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent strengths,” explains Milan Kalawadia, CEO, North America Generics, Dr Reddy’s Laboratories, Inc. “The first-to-market launch is a testament to our deep capabilities in bringing store-brand equivalents of OTC brands in the US market. We are excited to deepen our collaboration with our retail customers through this important addition to our store-brand portfolio.”

Dr Reddy’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% is available in a 2.5 mL bottle.

Read Next